The Role of Radical Surgery in Carcinoma of the Endometrium

Clinical Oncology

Volumn 20, Issue 6, 2008, Pages 448-456

  Holland, C M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Endometrial carcinoma; morbidity; radical surgery; survival

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; PLATINUM COMPLEX;

ADJUVANT THERAPY; ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMORBIDITY; CYTOREDUCTIVE SURGERY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; LAPAROTOMY; LYMPHADENECTOMY; METASTASIS; MORBIDITY; PELVIS SURGERY; PRIORITY JOURNAL; QUALITY OF LIFE; RADICAL HYSTERECTOMY; UTERINE CERVIX;

DISEASE PROGRESSION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; SURVIVAL; TREATMENT OUTCOME;

EID: 46149098327     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.03.012     Document Type: Article

References (53)

1. International Federation of Gynaecology and Obstetrics. Corpus cancer staging. Int J Gynecol Obstet 28 (1989) 189-190
2. Kitchener H.C.R.C., Swart A.M.C., and Amos C.L. ASTEC (surgery component): a study in the treatment of endometrial cancer. A randomized trial of lymphadenectomy in the treatment of endometrial cancer. ESGO 2005. Int J Gynecol Cancer 15 Suppl 2 (2005) 77 [abstract 00094]
3. Creasman W.T., Morrow C.P., Bundy B.N., Homesley H.D., Graham J.E., and Heller P.B. Surgical pathological spread patterns of endometrial cancer - a gynecologic oncology group study. Cancer 60 8 (1987) 2035-2041
4. Johnson N., and Cornes P. Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta-analysis. BJOG 114 11 (2007) 1313-1320
5. Creutzberg C.L., van Putten W.L.J., Koper P.C., et al. Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol Oncol 89 2 (2003) 201-209
6. Gehrig P.A., Van Le L., and Fowler W.C. The role of omentectomy during the surgical staging of uterine serous carcinoma. Int J Gynecol Cancer 13 2 (2003) 212-215
7. Grice J., Ek M., Greer B., et al. Uterine papillary serous carcinoma. Evaluation of long-term survival in surgically staged patients. Gynecol Oncol 69 1 (1998) 69-73
8. Havrilesky L.J., Secord A.A., Bae-Jump V., et al. Outcomes in surgical stage I uterine papillary serous carcinoma. Gynecol Oncol 105 3 (2007) 677-682
9. Thomas M.B., Mariani A., Cliby W.A., Keeney G.A., Podratz K.C., and Dowdy S.C. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma. Gynecol Oncol 107 2 (2007) 186-189
10. Creasman W.T., Kohler M.F., Odicino F., Maisonneuve P., and Boyle P. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium. Gynecol Oncol 95 3 (2004) 593-596
11. Abeler V.M., Vergote I.B., Kjorstad K.E., and Trope C.G. Clear cell carcinoma of the endometrium - prognosis and metastatic pattern. Cancer 78 8 (1996) 1740-1747
12. Murphy K.T., Rotmensch J., Yamada S.D., and Mundt A.J. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 55 5 (2003) 1272-1276
13. McCluggage W.G. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer 12 6 (2002) 687-690
14. Major F.J., Blessing J.A., Silverberg S.G., et al. Prognostic factors in early-stage uterine sarcoma - a Gynecologic Oncology Group study. Cancer 71 4 (1993) 1702-1709
15. Huh W.K., Powell M., Leath C.A., et al. Uterine papillary serous carcinoma: comparisons of outcomes in surgical stage I patients with and without adjuvant therapy. Gynecol Oncol 91 3 (2003) 470-475
16. Piver M.S., Rutledge F., and Smith J.P. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 44 2 (1974) 265-272
17. Holland C.M., and Shafi M.I. Radical hysterectomy. Best Pract Res Clin Obstet Gynaecol 19 3 (2005) 387-401
18. Yura Y., Tauchi K., Koshiyama M., et al. Parametrial involvement in endometrial carcinomas: its incidence and correlation with other histological parameters. Gynecol Oncol 63 1 (1996) 114-119
19. Sato R., Jobo T., and Kuramoto H. Parametrial spread is a prognostic factor in endometrial carcinoma. Eur J Gynaecol Oncol 24 3-4 (2003) 241-245
20. Tamussino K.F., Reich O., Gucer F., et al. Parametrial spread in patients with endometrial carcinoma undergoing radical hysterectomy. Int J Gynecol Cancer 10 4 (2000) 313-317
21. Kinsella T., Bloomer W.D., Lavin P.T., and Knapp R.C. Stage II endometrial carcinoma: 10-year follow-up of combined radiation and surgical treatment. Gynecol Oncol 10 (1980) 290-297
22. Larson D.M., Copeland L.J., Gallager H.S., Kong J.P., Wharton J.T., and Stringer C.A. Stage II endometrial carcinoma: results and complications of a combined radiotherapeutic-surgical approach. Cancer 61 (1988) 1528-1534
23. Calais G., Lefloch O., Descamps P., Vitu L., and Lansac J. Radical hysterectomy for stage-I and stage-II endometrial carcinoma - a retrospective analysis of 179 cases. Int J Radiat Oncol Biol Phys 20 4 (1991) 677-683
24. Nahhas W.A., Whitney C.W., Stryker J.A., Curry S.L., Chung C.K., and Mortel R. Stage II endometrial carcinoma. Gynecol Oncol 10 (1980) 303-311
25. Eltabbakh G.H., and Moore A.D. Survival of women with surgical stage II endometrial cancer. Gynecol Oncol 74 1 (1999) 80-85
26. Boothby R.A., Carlson J.A., Neiman W., et al. Treatment of stage-II endometrial carcinoma. Gynecol Oncol 33 2 (1989) 204-208
27. Mariani A., Webb M.J., Keeney G.L., Calori G., and Podratz K.C. Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement. Gynecol Oncol 83 1 (2001) 72-80
28. Sartori E., Gadducci A., Landoni F., et al. Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy. Int J Gynecol Cancer 11 6 (2001) 430-437
29. Boente M.P., Yordan E.L., McIntosh D.G., et al. Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement. Gynecol Oncol 51 3 (1993) 316-322
30. Cornelison T.L., Trimble E.L., and Kosary C.L. SEER data, corpus uteri cancer: treatment trends versus survival for FIGO stage II, 1988-1994. Gynecol Oncol 74 3 (1999) 350-355
31. Pecorelli S., Creasman W.T., Petterson F., Benedet J.L., and Shepherd J.H. FIGO annual report on the results of treatment in gynecologic cancer. J Epidemiol Biostat 3 (1998) 35-62
32. Connell P.P., Rotmensch J., Waggoner S., and Mundt A.J. The significance of adnexal involvement in endometrial carcinoma. Gynecol Oncol 74 1 (1999) 74-79
33. Sutton G., Axelrod J.H., Bundy B.N., et al. Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study. Gynecol Oncol 97 3 (2005) 755-763
34. Pliskow S., Penalver M., and Averette H.E. Stage III and stage IV endometrial carcinoma - a review of 41 cases. Gynecol Oncol 38 2 (1990) 210-215
35. Chi D.S., Welshinger M., Venkatraman E.S., and Barakat R.R. The role of surgical cytoreduction in stage IV endometrial carcinoma. Gynecol Oncol 67 1 (1997) 56-60
36. Bristow R.E., Zerbe M.J., Rosenshein N.B., Grumbine F.C., and Montz F.J. Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival. Gynecol Oncol 78 2 (2000) 85-91
37. Goff B.A., Goodman A., Muntz H.G., Fuller A.F., Nikrui N., and Rice L.W. Surgical stage IV endometrial carcinoma - a study of 47 cases. Gynecol Oncol 52 2 (1994) 237-240
38. Hoskins W.J. Epithelial ovarian carcinoma - principles of primary surgery. Gynecol Oncol 55 3 (1994) S91-S96
39. Memarzadeh S., Holschneider C.H., Bristow R.E., et al. FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival. Int J Gynecol Cancer 12 5 (2002) 454-458
40. Thomas M.B., Mariani A., Cliby W.A., Keeney G.L., Podratz K.C., and Dowdy S.C. Role of cytoreduction in stage III and IV uterine papillary serous carcinoma. Gynecol Oncol 107 2 (2007) 190-193
41. Wylie J., Irwin C., Pintilie M., et al. Results of radical radiotherapy for recurrent endometrial cancer. Gynecol Oncol 77 1 (2000) 66-72
42. Hoekstra C.J.M., Koper P.C.M., and Vanputten W.L.J. Recurrent endometrial adenocarcinoma after surgery alone - prognostic factors and treatment. Radiother Oncol 27 2 (1993) 164-166
43. Sears J.D., Greven K.M., Hoen H.M., and Randall M.E. Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer. Cancer 74 4 (1994) 1303-1308
44. Morris M., Alvarez R.D., Kinney W.K., and Wilson T.O. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration. Gynecol Oncol 60 2 (1996) 288-291
45. Barakat R.R., Goldman N.A., Patel D.A., Venkatraman E.S., and Curtin J.P. Pelvic exenteration for recurrent endometrial cancer. Gynecol Oncol 75 1 (1999) 99-102
46. Nezhat F., Hayes M.P., Peiretti M., and Rahaman J. Laparoscopic radical parametrectomy and partial vaginectomy for recurrent endometrial cancer. Gynecol Oncol 104 2 (2007) 494-496
47. Scarabelli C., Campagnutta E., Giorda G., et al. Maximal cytoreductive surgery as a reasonable therapeutic alternative for recurrent endometrial carcinoma. Gynecol Oncol 70 1 (1998) 90-93
48. Campagnutta E., Giorda G., De Piero G., et al. Surgical treatment of recurrent endometrial carcinoma. Cancer 100 1 (2004) 89-96
49. Awtrey C.S., Cadungog M.G., Leitao M.M., et al. Surgical resection of recurrent endometrial carcinoma. Gynecol Oncol 102 3 (2006) 480-488
50. Bristow R.E., Santillan A., Zahurak M.L., Gardner G.J., Giuntoli R.L., and Armstrong D.K. Salvage cytoreductive surgery for recurrent endometrial cancer. Gynecol Oncol 103 1 (2006) 281-287
51. Mannel R.S., Berman M.L., Walker J.L., Manetta A., and Disaia P.J. Management of endometrial cancer with suspected cervical involvement. Obstet Gynecol 75 6 (1990) 1016-1022
52. Cunha T.M., Felix A., and Cabral I. Preoperative assessment of deep myometrial and cervical invasion in endometrial carcinoma: comparison of magnetic resonance imaging and gross visual inspection. Int J Gynecol Cancer 11 2 (2001) 130-136
53. Kupelian P.A., Eifel P.J., Tornos C., Burke T.W., Delclos L., and Oswald M.J. Treatment of endometrial carcinoma with radiation-therapy alone. Int J Radiat Oncol Biol Phys 27 4 (1993) 817-824